TrialBritish journal of cancer2017

Chemotherapy vs tamoxifen in platinum-resistant ovarian cancer: a phase III, randomised, multicentre trial (Ovaresist).

Kristina Lindemann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.